InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025)
InMed Pharmaceuticals' (INM) quarterly Change in Inventory came in at $127091.0 in Q4 2025, up 208.89% year-on-year from $41144.7 in Q4 2024, and up 280.61% quarter-over-quarter from -$70366.0 in Q3 2025.
InMed Pharmaceuticals (INM) Change in Inventory (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Change in Inventory history runs 4 years deep, the most recent figure standing at $127091.0 for Q4 2025.
- On a quarterly basis, Change in Inventory rose 208.89% year-over-year to $127091.0 in Q4 2025; TTM through Dec 2025 was -$85458.0, a 121.32% decrease from a year earlier, with the FY2025 full-year figure at -$283151.0, down 327.59% from the prior year.
- Change in Inventory climbed to $127091.0 in Q4 2025 per INM's latest filing, from -$70366.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.1 million in Q2 2022 and bottomed at -$390329.0 in Q3 2023.
- The 4-year median for Change in Inventory is -$47308.5 (2024), against an average of $40239.1.
- Across the five-year window, Change in Inventory surged 399.09% in 2024 and tumbled 190.16% in 2025, its largest moves.
- Year by year, Change in Inventory stood at -$165017.0 in 2022, then sank by 31.98% to -$217784.0 in 2023, then jumped by 46.41% to -$116717.0 in 2024, then soared by 208.89% to $127091.0 in 2025.
- Per Business Quant, the three latest INM Change in Inventory figures stand at $127091.0 (Q4 2025), -$70366.0 (Q3 2025), and $147203.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,091.00 |
| Dec 31, 2025 | 127,091.00 |
| Sep 30, 2025 | -70,366.00 |
| Sep 30, 2025 | -70,366.00 |
| Jun 30, 2025 | 147,203.00 |
| Jun 30, 2025 | 147,203.00 |
| Mar 31, 2025 | -289,386.00 |
| Mar 31, 2025 | -289,386.00 |
| Dec 31, 2024 | -116,717.00 |
| Dec 31, 2024 | -116,717.00 |
| Sep 30, 2024 | -24,251.00 |
| Sep 30, 2024 | -24,251.00 |
| Jun 30, 2024 | 92,780.00 |
| Jun 30, 2024 | 92,780.00 |
| Mar 31, 2024 | 449,113.00 |
| Mar 31, 2024 | 449,113.00 |
| Dec 31, 2023 | -217,784.00 |
| Dec 31, 2023 | -217,784.00 |
| Sep 30, 2023 | -390,329.00 |
| Sep 30, 2023 | -390,329.00 |